medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2017, Number 1

Next >>

Salud Mental 2017; 40 (1)

Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico

Marín-Navarrete R, Magis-Rodríguez C, Strathdee SA

Language: English
References: 49
Page: 1-4
PDF size: 203.77 Kb.


Text Extraction

Epidemiology of STI in substance abusers According to international reports, Mexico has a high prevalence of sexually transmitted infections (STIs), such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). There are approximately 34 million people infected with HIV (National Center for Prevention and Control of HIV-AIDS [CENSIDA], 2011), between 130 and 150 million with HCV (WHO, 2014a), approximately 400 million with HBV (Hepatitis B Foundation, 2014), and 12 million infected with syphilis every year (WHO, 2014b).
Great strides have been made in the understanding, treatment and prevention of STIs. For example, the updating of transfusion protocols and standards in 2000 has significantly reduced the incidence of HCV infections by this means (Mathers et al., 2008). On the scientific and public health policy agendas, however, concern remains about specific populations with a greater risk of infection than the general population, such as substance abusers, who are estimated to have a high prevalence of STI (Scheinmann et al., 2007).


REFERENCES

  1. Aceijas, C. & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal on Drug Policy, 18, 352-358. DOI: http://dx.doi.org/10.1016/j.drugpo.2007.04.004

  2. Alvarado-Esquivel, C., Sablon, E., Martinez-Garcia, S. & Estrada-Martinez, Z. (2005). Hepatitis virus and HIV infections in inmutes of a state correccional facility in Mexico. Epidemiology & Infection, 133, 679-685. DOI: https://doi. org/10.1017/S0950268805003961

  3. Anaya, H. D., Hoang, T., Golden, J. F., Goetz, M. B., Gifford, A., Bowman, C., … Asch, S. M. (2008). Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. Journal of General Internal Medicine, 23(6), 800-7. DOI:10.1007/s11606-008-0617-x

  4. Barta, W.D., Portnoy, D.B., Kiene, S.M., Tennen, H., Abu-Hasaballah, K.S. & Ferrer, R. (2008). A daily process investigation of alcohol-involved sexual risk behavior among economically disadvantaged problem drinkers living with HIV/ AIDS. AIDS and Behavior, 12, 729-740. DOI: 10.1007/s10461-007-9342-4

  5. Brown, J.L. & Vanable, P.A. (2007). Alcohol use, partner type, and risky sexual behavior among college students: Findings from an event level study. Addictive Behaviors, 32, 2940-2952. http://dx.doi.org/10.1016/j.addbeh.2007.06.011

  6. Campollo, O., Román, S., Panduro, A., Hernández, G., Díaz-Barriga, L., Balanzario, M.C. & Cunningham, J.K. (2012). Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug and Alcohol Dependence, 123, 269-272. http://dx.doi.org/10.1016/j.drugalcdep.2011.11.009

  7. Centro Nacional para la Prevención y Control del VIH-Sida (2006). Guía para la aplicación de la prueba rápida. México: SSA.

  8. Centro Nacional para la Prevención y Control del VIH-Sida (2011). El VIH/SIDA en México 2011. Numeralia epidemiológica. México: SSA.

  9. Cohen, M. S., & Gay, C. L. (2010). Treatment to prevent transmission of HIV-1. Clinical Infectious Diseases, 50(Supplement 3), S85-S95. DOI: 10.1086/651478

  10. Deiss, R., Lozada, R.M., Burgos, J.L., Strahdee, S.A., Gallardo, M., Cuevas, J., & Garfein, R.S. (2012). HIV Prevalence and Sexual Risk Behavior among Non-Injection Drug Users in Tijuana, Mexico. Global Public Health, 7, 175-183. DOI: http://dx.doi.org/10.1080/17441692.2010.549141

  11. Edlin, B.R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36, S210-9. DOI: 10.1002/hep.1840360727

  12. Evon, D. M., Esserman, D. A, Bonner, J. E., Rao, T., Fried, M. W., & Golin, C. E. (2013). Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. Journal of Viral Hepatitis, 20(8), 536-49. DOI: 10.1111/jvh.12079

  13. Grebely, J. & Tyndall, M.W. (2011). Management of HCV and HIV infections among people who inject drugs. Current Opinion in HIV and AIDS, 6, 501-7. DOI: 10.1097/COH.0b013e32834bcb36

  14. Hall, H. I., Holtgrave, D. R., & Maulsby, C. (2012). HIV transmission rates from persons living with HIV who are aware and unaware of their infection. Aids, 26(7), 893-896. DOI: 10.1097/QAD.0b013e328351f73f

  15. Hepatitis B Foundation. (2014). Statistics. Available in: http://www.hepb.org/hepb/ statistics.htm

  16. Ho, S.B., Groessl, E., Dollarhide, A., Robinson, S., Kravetz, D., & Dieperink, E. (2008). Management of chronic hepatitis C in veterans: the potential of integrated care models. The American Journal of Gastroenterology, 103, 1810-23. DOI:10.1111/j.1572-0241.2008.01877.x

  17. Kyle, T. L., Horigian, V. E., Tross, S., Gruber, V. A., Pereyra, M., Mandler, R. N., ... & Metsch, L. R. (2015). Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS and Behavior, 19(3), 536-542. DOI: 10.1007/s10461-014-0864-2

  18. Lai, C., Gane, E., Liaw, Y. Hsu, C., Thongsawsat, S., Wang, Y… Brown, N. A. (2007). Telbivudine versus lamivudine in patients with chronic hepatitis B. New England Journal of Medicine, 357, 2576-2588. DOI: 10.1056/NEJMoa066422

  19. Lalesta, M., Dillon, B., Padilla, S., Brooks, L., Raveneau, L., & Metcalf, C. (2000). Experience with HIV/STD prevention counseling with a rapid HIV test and counseling quality assurance (Respect-2). 2000 National STD Prevention Conference, Milwaukee, WI.

  20. Leber, W., McMullen, H., Anderson, J., Marlin, N., Santos, A. C., Bremner, S., ... & Griffiths, C. (2015). Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial. The Lancet HIV, 2(6), e229-e235. DOI: http://dx.doi.org/10.1016/S2352-3018(15)00059-4

  21. Lehman, J.S., Allen, D.M., Green, T.A. & Onorato, I.M. (1994). HIV infection among non–injecting drug usersentering drug treatment, United States, 1989–1992. Field Services Branch. AIDS, 8, 1465-1469.

  22. Lieveld, F. I., van Vlerken, L. G., Siersema, P. D., & van Erpecum, K. J. (2013). Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Annals of Hepatology, 12(3), 380-91.

  23. Lozano-Verduzco, I., Marín-Navarrete, R., Romero-Mendoza, M., & Tena-Suck, A. (2016). Experiences of Power and Violence in Mexican Men Attending Mutual- Aid Residential Centers for Addiction Treatment. American Journal of Men’s Health. 10(3) 237–249. DOI: 10.1177/1557988314565812

  24. Lozano-Verduzco, I., Mendoza-Romero, M. & Marín-Navarrete, R. (2016). Violence narratives of Mexican women treated in mutual-aid residential centers for addiction treatment. Substance Abuse Treatment, Prevention, and Policy. 11:39, 1-10. DOI: 10.1186/s13011-016-0083-0

  25. Magis-Rodriguez, C., Brouwer, K.C., Morales, S., Gayet, C., Lozada, R., Ortíz-Mondragón, R.,... Strathdee, S.A. (2005). HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. Journal of Psychoactive Drugs, 37, 333–339. DOI: http://dx.doi.org/10 .1080/02791072.2005.10400528

  26. Marín-Navarrete, R., Medina-Mora ME, Horigian VE, Salloum I., Villalobos-Gallegos L. & Fernandez-Mondragón, J. (2016). Co- Occurring disorders: A challenge for Mexican community based-residential care facilities for substance use. Journal of Dual Diagnosis, 12:3-4, 261-270. DOI: 10.1080/15504263.2016.1220207.

  27. Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39(4), 446-453. DOI: 10.1097/01.qai.0000151079.33935.79

  28. Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., ... & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet, 372(9651), 1733-1745. DOI: http://dx.doi.org/10.1016/S0140-6736(08)61311-2

  29. Mathurin, P., Canva, V., Dharancy, S. & Paris, J.C. (2002). Treatment of chronic hepatitis C and alcohol consumption. Gastroentérologie Clinique et Biologique, 26, B248-51.

  30. Moirand, R., Bilodeau, M., Brissette, S. & Bruneau, J. (2007). Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Canadian Journal of Gastroenterology & Hepatolgy, 21, 355-361. DOI: http://dx.doi.org/10.1155/2007/576765

  31. Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D. & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378, 571–583. DOI: http://dx.doi.org/10.1016/S0140-6736(11)61097-0

  32. Organización Mundial de la Salud (OMS, 2014a). Hepatitis C. Disponible en: http:// www.who.int/mediacentre/factsheets/fs164/es/ Organización Mundial de la Salud (OMS, 2014b). Eliminación Mundial de la Sífilis Congénita: fundamentos y estrategia para la acción. Disponible en: http://www. who.int/reproductivehealth/publications/rtis/9789241595858/es/ Pagano A, García V, Recarte C, Lee JP. Sociopolitical contexts for addiction recovery: Anexos in U.S. Latino communities. International Journal of Drug Policy. 2016; 37:52-9. DOI: 10.1016/j.drugpo.2016.08.002.

  33. Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., . . . Busch, M. P. (2009). Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. Journal of Infectious Diseases, 200, 1216–1226. DOI: 10.1086/605947

  34. Pai, N.P., Vadnais, C., Denkinger, C., Engel, N. & Pai, M. (2012). Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low And Middle-Income Countries. PLoS Medicine, 9, 1-7. DOI: http://dx.doi. org/10.1371/journal.pmed.1001306

  35. Peters, M.G. & Terrault, N.A. (2002). Alcohol use and hepatitis C. Hepatology, 36, S220-5. DOI: 10.1053/jhep.2002.36811

  36. Piasecki, B. A., Lewis, J. D., Reddy, K. R., Bellamy, S. L., Porter, S. B., Weinrieb, R. M., . . . Chang, K. M. (2004). Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology, 40, 892–899. DOI: 10.1002/hep.1840400419

  37. Poustchi, H., Esmaili, S., Mohamadkhani, A., Nikmahzar, A., Pourshams, A., Sepanlou, S. G., . . . Malekzadeh, R. (2011). The impact of illicit drug use on spontaneous hepatitis C clearance: Experience from a large cohort population study. PLoS ONE, 6(8), e23830. DOI: http://dx.doi.org/10.1371/journal.pone.0023830

  38. Prevots, D.R., Allen, D.M., Lehman, J.S., Green, T.A., Petersen, L.R. & Gwinn, M. (1996). Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988– 1993. American Journal of Epidemiology, 143, 733–742. DOI: https://doi. org/10.1093/oxfordjournals.aje.a008807

  39. Quer, J. y Estaban-Mur, J. I. (2014). Hepatitis C virus: Epidemiology and prevention. in Thomas, H. C., Lok, A. S. F., Locarnini, S. A., & Zuckerman, A. J. (Eds.). Viral Hepatitis (246-265). UK: Wiley Blackwell

  40. Rosenberg, S. D., Goodman, L. a, Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., … Salyers, M. P. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91(1), 31-7.

  41. Schackman, B. R., Metsch, L. R., Colfax, G. N., Leff, J. A., Wong, A., Scott, C. A., ... & Walensky, R. P. (2013). The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug and alcohol dependence, 128(1), 90-97. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2012.08.009

  42. Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: a systematic review. Drug and alcohol dependence, 89(1), 1-12. DOI: http:// dx.doi.org/10.1016/j.drugalcdep.2006.11.014

  43. Strathdee, S.A., Philbin, M.M., Semple, S.J., Pu, M., Orozovich, P., Martínez, G.,… Patterson, T.L. (2008). Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence, 92, 132– 40. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2007.07.001

  44. Swan, D., Long, J., Carr, O., Flanagan, J., Irish, H., Keating, S.,… Cullen, W. (2010). Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care and STDS, 24, 753–62. DOI:10.1089/apc.2010.0142.

  45. The PLoS Medicine Editors (2011). Speed and Convenience Aren’t Everything with Diagnostics. PLoS Medicine, 8, e1001113. DOI: http://dx.doi.org/10.1371/journal. pmed.1001113

  46. Treloar, C., Hull, P., Dore, G.J. & Grebely, J. (2012). Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug and Alcohol Review, 31, 918–24. DOI: 10.1111/j.1465- 3362.2012.00468.x

  47. Treloar, C., Newland, J., Rance, J. & Hopwood, M. (2010). Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis, 17, 839–44. DOI: 10.1111/j.1365-2893.2009.01250.x

  48. Viani, R. M., Araneta, M. R. G., Ruiz-Calderon, J., Hubbard, P., Lopez, G., Chacón- Cruz, E., & Spector, S. A. (2006). Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(1), 87-92.

  49. White, E.F., Garfein, R.S., Brouwer, K.C., Lozada, R., Ramos, R., Firestone, M., et al. (2007). Prevalence of hepatitis C virus and HIV among injection drug users in two mexican cities bordering the US. Salud Pública Mexico, 49, 165-172. DOI: http://dx.doi.org/10.1590/S0036-36342007000300001




2020     |     www.medigraphic.com